Optimising vaccine immunogenicity in ageing populations: key strategies
- 23 September 2024
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 25 (1) , e23-e33
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 146 references indexed in Scilit:
- The inhibitory effect of rBCG on EB virus-positive tumours using an EB virus fusion geneApplied Microbiology and Biotechnology, 2021
- Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 YearsJAMA, 2021
- Twenty years of research on HPV vaccines based on genetically modified lactic acid bacteria: an overview on the gut-vagina axisCellular and Molecular Life Sciences, 2020
- Composition of the murine gut microbiome impacts humoral immunity induced by rabies vaccinesClinical and Translational Medicine, 2020
- BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against TuberculosisCell, 2018
- Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung CancerCell, 2017
- Aging affects B‐cell antigen receptor repertoire diversity in primary and secondary lymphoid tissuesEuropean Journal of Immunology, 2015
- Function of a Foxp3 cis -Element in Protecting Regulatory T Cell IdentityCell, 2014
- Impact of aging on dendritic cell functions in humansAgeing Research Reviews, 2011
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the United StatesJAMA, 2003